Acute Ischemic Stroke

Overview

According to the American Heart Association Heart Disease and Stroke Statistics - 2013 Update, approximately 795,000 people experience a new or recurrent stroke each year. Stroke management is time-sensitive and clinicians working within emergency medical services are generally the first to evaluate a patient having an acute stroke. Consequently, emergency department staff are often in the position to make critical decisions regarding treatment. They must coordinate care so that a systems-based approach is utilized, while adhering to the published literature regarding intravenous recombinant tissue plasminogen activator (IV rtPA) in acute ischemic stroke management.

During this CME meeting series, leading emergency medicine physicians and neurologists will review the latest advances in the diagnosis and management of patients presenting with acute ischemic stroke, as well as the latest technological advances in telemedicine.

The meetings will incorporate an interactive case-based approach to present the most current data on the following topics:

• Time is Brain: Making the Correct Diagnosis and Evaluating for Thrombolysis
• Management of Acute Ischemic Stroke with IV Thrombolysis: What the Emergency Physician Needs to Know
• Endovascular Procedures: What are the Latest Data?
• The Role of Telemedicine in Stroke Care

Target Audience
The intended learners for the activity are emergency physicians and other healthcare professionals involved in the treatment of patients with acute ischemic stroke.

Learning Objectives
Upon successful completion of the activity, participants will be able to:

• Critically analyze eligibility criteria for administering IV thrombolysis and be prepared to administer to eligible patients following an acute ischemic stroke.
• Evaluate evidence-based management options of patients who present with acute ischemic stroke beyond the optimal 3-hour treatment window.
• Create an individualized treatment plan for acute ischemic stroke patients that offers the best chance for safe reperfusion.
• Review the clinical evidence examining the benefits and risks of early treatment with IV rtPA or endovascular procedures for acute ischemic stroke.

CME Information
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Vindico Medical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In accordance with the Accreditation Council for Continuing Medical Education's Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

Faculty, topics, program schedule and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program committee.

Upon successful completion of the activity, participants will be able to:

• Critically analyze eligibility criteria for administering IV thrombolysis and be prepared to administer to eligible patients following an acute ischemic stroke.
• Evaluate evidence-based management options of patients who present with acute ischemic stroke beyond the optimal 3-hour treatment window.
• Create an individualized treatment plan for acute ischemic stroke patients that offers the best chance for safe reperfusion.
• Review the clinical evidence examining the benefits and risks of early treatment with IV rtPA or endovascular procedures for acute ischemic stroke.

The intended learners for the activity are emergency physicians and other healthcare professionals involved in the treatment of patients with acute ischemic stroke. 

To register for a meeting in your area, please visit http://www.strokemeetings.com or give us a call at 855-276-6855.

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Vindico Medical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

Faculty, topics, program schedule and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program committee.